An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome

BACKGROUND: Minocycline, a member of the tetracycline family, has a low risk of adverse effects and an ability to improve behavioral performance in humans with cognitive disruption. We performed a single-arm open-label trial in which 25 children diagnosed with Angelman syndrome (AS) were administere...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Neurol
Prif Awduron: Grieco, Joseph C, Ciarlone, Stephanie L, Gieron-Korthals, Maria, Schoenberg, Mike R, Smith, Amanda G, Philpot, Rex M, Heussler, Helen S, Banko, Jessica L, Weeber, Edwin J
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2014
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4276108/
https://ncbi.nlm.nih.gov/pubmed/25491305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-014-0232-x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg